Home    eJManager.com Add Your Journal   |    Follow on Twitter   |    Subscribe to List

Directory for Medical Articles
 

Open Access

-



Significance of Aldose Reductase in Diabetic cataract

Geeta Bhatia; Subodhini Abhang; A. N. Sontakke.

Abstract
Background: Cataract is a major cause of blindness. Diabetes mellitus is a major risk factor for the development of cataract. Diabetic patients have 25 times higher risk of cataract than non-diabetic population. The metabolic changes accompanying hyperglycemia is increased activity of the polyol pathway and aldose reductase (AR) is a key enzyme of polyol pathway. Aldose reductase is responsible for generation of more oxidative stress by decreasing GSH in diabetic patients which is thought to be a major factor to initiate the process of cataractogenesis. The present study was designed to determine significance of aldose reductase diabetic cataract and its correlation with reduced glutathione (GSH) and Malondialdehyde (MDA) in diabetic cataract patients.
Methods: In this study we measured MDA as oxidative stress marker & Glycated Hb (HbA1c) glycemic index marker levels of GSH and AR in erythrocytes of Type2 diabetic cataract patients (n = 30) and non diabetic senile cataract patients (n=30) compared with age matched normal controls(n=30).
Results: We found increased levels of AR, HbA1c and MDA, and decreased levels of GSH in diabetic cataract patients compared to non diabetic senile cataract patients and normal controls.
Conclusions: From the result it is concluded that AR play a major role in generation of more oxidative stress in diabetic patients which may be the cause of early cataractogenesis in diabetic patients as compared to non diabetic senile cataract patients.

Key words: Cataract;Aldose Reductase (AR);Malondialdehyde (MDA);Reduced Glutathione (GSH);Glycated Hb (HbA1c)


Full text links

Share this Article




ScopeMed Home
Follow ScopeMed on Twitter
Article Tools
Job Opportunities/Service Offers
eJManager OJMS
eJPort Journal Hosting
About ScopeMed
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Service of eJManager LLC Publishing for Scientific Publications. Copyright © ScopeMedź Information Services.
Scopemed Buttons